Home › Stock analysis › CL
Colgate Palmolive (CL) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
CL ends flat (-0.1%) to $92.67. Closed at $92.67, -0.12% vs the prior close of $92.78. Day range $92.12–$95.33, opened at $94.26.
Last close$92.67-0.12%
Day range92.12–95.33
Open94.26
Volume8.17M
52-week range74.55–99.33
Avg volume (20d)5.41M
CL daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — CL ends flat (-0.1%) to $92.67
- Closed at $92.67, -0.12% vs the prior close of $92.78. Day range $92.12–$95.33, opened at $94.26.
- Volume was 8.17M shares, 1.7x its 50-day average of 4.69M.
- Price is +4.0% vs its 50-day average ($89.13) and +4.2% vs its 200-day average ($88.92).
- 52-week range $74.55–$99.33; today's close sits at 73% of that range, 6.7% below the 52-week high.
Oct 14, 2026 — CL jumps 3.1% to $92.78, a 1-month high
- Closed at $92.78, +3.15% vs the prior close of $89.95. Day range $90.63–$92.87, opened at $90.63.
- Volume was 5.38M shares, 1.1x its 50-day average of 4.71M.
- Price is +4.1% vs its 50-day average ($89.15) and +4.4% vs its 200-day average ($88.85).
- 52-week range $74.55–$99.33; today's close sits at 74% of that range, 6.6% below the 52-week high.
Oct 13, 2026 — CL ends flat (-0.0%) to $89.95
- Closed at $89.95, -0.03% vs the prior close of $89.98. Day range $89.38–$91.05, opened at $90.92.
- Volume was 3.49M shares, 0.7x its 50-day average of 4.76M.
- Price is +0.9% vs its 50-day average ($89.14) and +1.3% vs its 200-day average ($88.79).
- 52-week range $74.55–$99.33; today's close sits at 62% of that range, 9.4% below the 52-week high.
Oct 12, 2026 — CL rises 1.9% to $89.98, a 1-month high, 3 up days in a row
- Closed at $89.98, +1.94% vs the prior close of $88.27. Day range $88.25–$89.98, opened at $88.34.
- Volume was 4.57M shares, 1.0x its 50-day average of 4.80M.
- Price is +0.9% vs its 50-day average ($89.14) and +1.4% vs its 200-day average ($88.74).
- 52-week range $74.55–$99.33; today's close sits at 62% of that range, 9.4% below the 52-week high.
- That makes 3 straight gains.
Oct 9, 2026 — CL ends flat (+0.2%) to $88.27, a 1-month high
- Closed at $88.27, +0.19% vs the prior close of $88.10. Day range $87.64–$88.66, opened at $87.67.
- Volume was 3.17M shares, 0.7x its 50-day average of 4.83M.
- Price is -1.0% vs its 50-day average ($89.17) and -0.5% vs its 200-day average ($88.69).
- 52-week range $74.55–$99.33; today's close sits at 55% of that range, 11.1% below the 52-week high.
Oct 8, 2026 — CL rises 1.0% to $88.10, a 1-month high
- Closed at $88.10, +1.02% vs the prior close of $87.21. Day range $87.09–$88.38, opened at $87.28.
- Volume was 4.08M shares, 0.8x its 50-day average of 4.87M.
- Price is -1.3% vs its 50-day average ($89.23) and -0.6% vs its 200-day average ($88.64).
- 52-week range $74.55–$99.33; today's close sits at 55% of that range, 11.3% below the 52-week high.
Oct 7, 2026 — CL ends flat (-0.0%) to $87.21
- Closed at $87.21, -0.05% vs the prior close of $87.25. Day range $87.20–$88.05, opened at $87.65.
- Volume was 3.77M shares, 0.8x its 50-day average of 4.89M.
- Price is -2.4% vs its 50-day average ($89.34) and -1.6% vs its 200-day average ($88.59).
- 52-week range $74.55–$99.33; today's close sits at 51% of that range, 12.2% below the 52-week high.
Oct 6, 2026 — CL rises 1.2% to $87.25
- Closed at $87.25, +1.23% vs the prior close of $86.19. Day range $86.23–$88.05, opened at $86.55.
- Volume was 4.01M shares, 0.8x its 50-day average of 4.89M.
- Price is -2.5% vs its 50-day average ($89.45) and -1.5% vs its 200-day average ($88.55).
- 52-week range $74.55–$99.33; today's close sits at 51% of that range, 12.2% below the 52-week high.
Oct 5, 2026 — CL rises 2.3% to $86.19
- Closed at $86.19, +2.29% vs the prior close of $84.26. Day range $84.33–$86.36, opened at $84.51.
- Volume was 6.00M shares, 1.2x its 50-day average of 4.83M.
- Price is -3.7% vs its 50-day average ($89.54) and -2.6% vs its 200-day average ($88.51).
- 52-week range $74.55–$99.33; today's close sits at 47% of that range, 13.2% below the 52-week high.
Oct 2, 2026 — CL dips 0.3% to $84.26, a 3-month low, 4 down days in a row
- Closed at $84.26, -0.32% vs the prior close of $84.53. Day range $83.99–$84.83, opened at $84.59.
- Volume was 6.61M shares, 1.4x its 50-day average of 4.80M.
- Price is -6.0% vs its 50-day average ($89.64) and -4.8% vs its 200-day average ($88.47).
- 52-week range $74.55–$99.33; today's close sits at 39% of that range, 15.2% below the 52-week high.
- That makes 4 straight losses.
Things to know before you trade CL
- Last results release: Jul 31, 2026 (8-K Item 2.02). Previous ones: May 1, 2026, Jan 30, 2026, Oct 31, 2025. Based on that rhythm, the next report is likely around Oct 30, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 0.93% (largest 3.1%). That is a relatively calm stock.
- Liquidity: about 5.41M shares (≈$501.19M) trade per day on average.
- 52-week position: $92.67 vs a range of $74.55–$99.33 (73% of the range).
- Dividends: last ex-dividend date Jul 20, 2026 ($0.53/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 15 sales; latest: Panagiotis Tsourapas sold 10,000 shares on Aug 24, 2026.
- Latest filings: 10-Q Jul 31, 2026; 8-K Jul 31, 2026; 8-K May 13, 2026.
- Share count: 797.17M shares outstanding (Jun 30, 2026), -1.4% vs a year earlier.
- Listing: NYSE · industry: Perfumes, Cosmetics & Other Toilet Preparations.
CL market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 94.26 | 95.33 | 92.12 | 92.67 | 8.17M |
| Oct 14, 2026 | 90.63 | 92.87 | 90.63 | 92.78 | 5.38M |
| Oct 13, 2026 | 90.92 | 91.05 | 89.38 | 89.95 | 3.49M |
| Oct 12, 2026 | 88.34 | 89.98 | 88.25 | 89.98 | 4.57M |
| Oct 9, 2026 | 87.67 | 88.66 | 87.64 | 88.27 | 3.17M |
| Oct 8, 2026 | 87.28 | 88.38 | 87.09 | 88.10 | 4.08M |
| Oct 7, 2026 | 87.65 | 88.05 | 87.20 | 87.21 | 3.77M |
| Oct 6, 2026 | 86.55 | 88.05 | 86.23 | 87.25 | 4.01M |
| Oct 5, 2026 | 84.51 | 86.36 | 84.33 | 86.19 | 6.00M |
| Oct 2, 2026 | 84.59 | 84.83 | 83.99 | 84.26 | 6.61M |
| Oct 1, 2026 | 84.79 | 85.19 | 84.33 | 84.53 | 5.02M |
| Sep 30, 2026 | 86.90 | 87.22 | 85.29 | 85.32 | 4.68M |
| Sep 29, 2026 | 85.84 | 86.51 | 85.58 | 86.46 | 4.48M |
| Sep 28, 2026 | 85.65 | 86.61 | 85.30 | 86.52 | 4.49M |
| Sep 25, 2026 | 85.09 | 86.14 | 85.05 | 86.06 | 3.54M |
| Sep 24, 2026 | 86.33 | 87.25 | 85.29 | 85.32 | 4.78M |
| Sep 23, 2026 | 86.77 | 87.40 | 85.77 | 85.93 | 6.22M |
| Sep 22, 2026 | 87.09 | 87.55 | 86.86 | 87.05 | 7.59M |
| Sep 21, 2026 | 87.26 | 87.27 | 86.03 | 86.26 | 7.28M |
| Sep 18, 2026 | 87.11 | 87.73 | 86.79 | 87.47 | 10.84M |
About Colgate Palmolive
Colgate Palmolive (CL) is listed on the NYSE and classified by the SEC under “Perfumes, Cosmetics & Other Toilet Preparations”. Its business address is in NEW YORK, NY. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 21665.
CL board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| John P Bilbrey | Director | Jul 2, 2026 |
| Christopher S. Boerner | Director | May 13, 2026 |
| John T Cahill | Director | Aug 7, 2026 |
| Lisa Edwards | Director | May 13, 2026 |
| C Martin Harris | Director | May 13, 2026 |
| Martina Hundmejean | Director | May 13, 2026 |
| Lorrie M Norrington | Director | Jul 2, 2026 |
| Kimberly A Nelson | Director | May 13, 2026 |
| Brian Newman | Director | Jul 2, 2026 |
| Noel R. Wallace | Chairman, President & CEO | Sep 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Jennifer Daniels | CLO and Secretary | Feb 25, 2026 |
| Betsy Fishbone | CLO and Secretary | Sep 18, 2026 |
| Shane Grant | COO, Americas | Sep 18, 2026 |
| John Hazlin | Chief Growth Officer | Sep 18, 2026 |
| Gregory Malcolm | EVP and Controller | Sep 18, 2026 |
| Sally Massey | Chief People Officer | Sep 18, 2026 |
| Stanley J Iii Sutula | Chief Financial Officer | Sep 18, 2026 |
| Panagiotis Tsourapas | COO, CD, EMEA, APac, Skin | Sep 18, 2026 |
| Noel R. Wallace | Chairman, President & CEO | Sep 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 24, 2026 | Panagiotis Tsourapas | Sale | 10,000 | $92.05 |
| Aug 6, 2026 | John T Cahill | Sale | 4,170 | $93.37 |
| Aug 5, 2026 | Noel R. Wallace | Sale | 161,021 | $92.52 |
| Aug 4, 2026 | Noel R. Wallace | Sale | 161,021 | $91.92 |
| May 15, 2026 | Gregory Malcolm | Sale | 2,300 | $88.44 |
| May 7, 2026 | Sally Massey | Sale | 8,599 | $87.41 |
| Feb 12, 2026 | Panagiotis Tsourapas | Sale | 15,000 | $97.81 |
| Feb 11, 2026 | Panagiotis Tsourapas | Sale | 35,000 | $94.61 |
| Feb 10, 2026 | John Hazlin | Sale | 20,989 | $94.25 |
| Feb 6, 2026 | Gregory Malcolm | Sale | 12,747 | $94.91 |
| Feb 5, 2026 | Sally Massey | Sale | 15,851 | $95.03 |
| Feb 4, 2026 | Stanley J Iii Sutula | Sale | 97,843 | $94.27 |
| Feb 4, 2026 | Jennifer Daniels | Sale | 22,000 | $94.34 |
| Feb 4, 2026 | Noel R. Wallace | Sale | 45,568 | $93.91 |
| Nov 21, 2025 | Sally Massey | Sale | 1,237 | $80.89 |
CL financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $20.38B | $2.13B | 2.63 | $4.20B |
| Dec 31, 2024 | $20.10B | $2.89B | 3.51 | $4.11B |
| Dec 31, 2023 | $19.46B | $2.30B | 2.77 | $3.75B |
| Dec 31, 2022 | $17.97B | $1.78B | 2.13 | $2.56B |
| Dec 31, 2021 | $17.42B | $2.17B | 2.55 | $3.33B |
Latest balance sheet: total assets $16.79B, total liabilities $16.22B, cash $1.37B (as of Jun 30, 2026).
CL earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 31, 2026 | 8-K Item 2.02 (results) | $91.30 |
| May 1, 2026 | 8-K Item 2.02 (results) | $87.26 |
| Jan 30, 2026 | 8-K Item 2.02 (results) | $90.29 |
| Oct 31, 2025 | 8-K Item 2.02 (results) | $77.05 |
| Aug 1, 2025 | 8-K Item 2.02 (results) | $83.51 |
| Apr 25, 2025 | 8-K Item 2.02 (results) | $93.91 |
| Jan 31, 2025 | 8-K Item 2.02 (results) | $86.70 |
| Jul 26, 2024 | 8-K Item 2.02 (results) | — |
| Apr 26, 2024 | 8-K Item 2.02 (results) | — |
| Jan 26, 2024 | 8-K Item 2.02 (results) | — |
| Oct 27, 2023 | 8-K Item 2.02 (results) | — |
| Jul 28, 2023 | 8-K Item 2.02 (results) | — |
More on CL
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.